SHORT DESCRIPTION

Semaglutide is a glucagon-like peptide-1 receptor agonist. It is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. Semaglutide is not for use in people with type 1 diabetes. Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in patients. The higher-dose formulation of Semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m2) or who are overweight (initial BMI ≥ 27 kg/m2) and have at least one weight-related comorbidity.